Demand forweight-loss drugs has grown at an astonishing rate in recent years, driving share prices of healthcare giants such ...

Discover the revival of the biotech sector, with IPOs resurging and promising weight loss drug potential, despite facing ...

Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop ...

Rivus already announced in August that the trial hit its key endpoint, but today fleshed out that win with some figures.

With the third quarter of 2024 ending, the discourse on the stock market for global equities has shifted back to interest ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard Jørgensen over the high price of the company’s diabetes and obesity drugs, Ozempic ...

Two naturally occurring molecules could be the key to sustained weight management, offering an organic alternative to ...

Roche said it plans to focus on five key therapeutic areas as part of its new pharma strategy through 2030. The company will prioritize work in the areas of neurology, oncology and hematology, ...

Purchases of size “small” women’s clothing increased 5 percent between 2022 and 2024 on New York’s Upper East Side — an affluent area with a high percentage of non-diabetic weight-loss drug ...

Some people have turned to compound pharmacies to replace drugs in short supply, but medical professionals warn of a new ...

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established drugmakers and an emerging market of compounded versions as telehealth ...